Radiation oncology: past achievements and ongoing controversies.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer Research

• Publication date

  1991-09-15

• Fields of study

  Medicine

• Identifiers
  PMID 1884382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Photodynamic therapy.

  1993cited by this paper
• The emerging biology of modern radiation oncology.

  1990cited by this paper
• Antitumor Drug Radiation Interactions

  1990cited by this paper
• Direct measurement of the concentration of oxygen in cells and

  1990cited by this paper
• Phototherapy of Cancer

  1990cited by this paper
• Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro.

  1990cited by this paper
• Three-dimensional display techniques in radiation therapy treatment planning.

  1989cited by this paper
• Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells.

  1989cited by this paper
• Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.

  1989cited by this paper
• A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.

  1988cited by this paper
• Chinese hamster pleiotropic multidrug-resistant cells are not radioresistant.

  1988cited by this paper
• Radioprotection by glutathione esters and cysteamine in normal and glutathione-depleted mammalian cells.

  1988cited by this paper
• Endogenous versus exogenous thiols in radioprotection.

  1988cited by this paper
• Postoperative radiation therapy of rectal cancer.

  1987cited by this paper
• The role of glutathione in radiation and drug induced cytotoxicity.

  1987cited by this paper
• Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.

  1987cited by this paper
• Effect of cisplatin resistance on cellular radiation response.

  1987cited by this paper
• Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung.

  1986cited by this paper
• Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.

  1986cited by this paper
• Conformation therapy: a method of improving the tumour treatment volume ratio.

  1986cited by this paper
• Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content.

  1986cited by this paper
• Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

  1986cited by this paper
• Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

  1986cited by this paper
• A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics.

  1986cited by this paper
• Adriamycin resistance, heat resistance and radiation response in Chinese hamster fibroblasts.

  1986cited by this paper
• Biologic basis for altered fractionation schemes

  1985cited by this paper
• The imaging revolution and radiation oncology: use of CT, ultrasound, and NMR for localization, treatment planning and treatment delivery.

  1985cited by this paper
• The effects of cellular glutathione elevation on the oxygen enhancement ratio.

  1985cited by this paper
• Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

  1985cited by this paper
• Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.

  1984cited by this paper
• Breur Medal acceptance speech: Past, present and future of interstitial radiation therapy.

  1983cited by this paper
• Radiation therapy with or without primary limited surgery for operable breast cancer: A 20‐year experience at the marseilles cancer institute

  1982cited by this paper
• SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.

  1981cited by this paper
• The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

  1981cited by this paper
• Fundamental questions in the combined use of radiation and chemicals in the treatment of cancer.

  1979cited by this paper
• Adriamycin resistance and radiation response.

  1977cited by this paper
• Carcinoma of the lung: results of treatment over ten years.

  1976cited by this paper
• Abdominal irradiation in non‐Hodgkin's lymphomas

  1976cited by this paper
• Bladder cancer: results of radiation therapy in 384 patients.

  1975cited by this paper
• External beam radiation therapy of primary carcinoma of the prostate

  1975cited by this paper
• Biological basis for high-LET radiotherapy.

  1973cited by this paper
• Cancer of the uterine cervix. Janeway lecture, 1970.

  1971cited by this paper
• Response to X-irradiation of a Tumour recurring after a TCD95 Radiation Dose

  1966cited by this paper
• Role of intensive radiotherapy in the management of Hodgkin's disease

  1966cited by this paper
• The radical radiotherapy of regionally localized Hodgkin's disease.

  1962cited by this paper
• Comparison of medium voltage and supervoltage roentgen therapy in the treatment of oropharynx cancers.

  1959cited by this paper
• CANCER OF THE UTERINE CERVIX

  1957cited by this paper
• ACTION OF X-RAYS ON MAMMALIAN CELLS

  1956cited by this paper

• Eli J. Glatstein: Inspiring and Provoking Critical Thinking

  2020cites this paper
• An Investigation of Glutathione-Platinum(II) Interactions by Means of the Flow Injection Analysis Using Glassy Carbon Electrode

  2007cites this paper
• In vivo measurement of tumor blood oxygenation by near-infrared spectroscopy: Immediate effects of pentobarbital overdose or carmustine treatment

  2005cites this paper
• Absorbed dose distribution of the auger emitters 67GA and 125I and the beta-emitters 67CU, 90Y, 131I, and 186RE as a function of tumor size, uptake, and intracellular distribution.

  1996cites this paper
• A dosimetric model for intrathecal treatment with 131I and 67Ga.

  1994cites this paper
• Therapeutic potential of intravenous 67‐gallium in non‐Hodgkin's lymphoma

  1993cites this paper